___

• 1. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N EnglJ Med 1979;301:61-8.
• 2. Baim DS. New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete. Curr Opin Cardiol 2004; 19:593-597.
• 3. Serruys PW, de Jaegere P, Kiemeneij F, et al. Acomparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med 1994;331:489-95.
• 4. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N EnglJ Med 1994;331:496-501.
• 5. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet 1998;352:673-81.
• 6. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kem MJ, King SB III, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for © 2005 by the American College of Cardiology Foundation and the American Heart Association, Inc.Percutaneous Coronary Intervention). American Heart Association Web Site. Available at: http://www.americanheart.org.
• 7. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) J Am Coll Cardiol 2002;39:1096-1103.
• 8. Levine GN, Kern MJ, Berger PB, et al. Management of Patients Undergoing Percutaneous Coronary RevascularizationAnn Intern Med. 2003;139:123-136.
• 9. Morice MÇ, Serruys PW, Sousa JE, et al. A randomized comparison of a siroiirnus-eluting ştent with a standard stent for coronary revascularization.N Enğl J Med 2002;346:1773-80. 10. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N EnglJ Med 2003;349:1315-23.
• 11. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
• 12. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293-304.
• 13. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-25.
• 14. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001 ;344:1117-24.
• 15. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992;326: 10-16.
• 16. Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet 1997;350: 461-468.
• 17. Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: Outcomes for patients with double vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME Investigators. J Am Coll Cardiol 1997;29: 1505-1511.
• 18. Laskey WK, Williams DO, Vlachos HA, et al. Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHL-BI) Dynamic Registry. Am J Cardiol. 2001;87:964-9.
• 19. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation. 2000;102:2945-51.
• 20. Laskey WK, Kimmel S, Krone RJ. Contemporary trends in coronary intervention:a report from the Registry of the Society for Cardiac Angiography and Interventions. Catheter Cardiovasc Interv. 2000;49:19-22.
• 21. Smith SC Jr, Dove JT, Jacobs AK, et al.. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37:2215-39.
• 22. Shah PB, Holper E, Hughes MD, Kunt RE. Asymptomatic CK-MB elevation after PCI is not correlated with late mortality [Abstract]. Circulation. 2001;104(SupplII):II-706.
• 23. Klein LW. Significance of creatine kinase release after coronary interventions. Catheter Cardiovasc Interv. 1999;48:130-2.
• 24. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001;104:642-7.
• 25. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-47.
• 26. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl JMed 1992; 326: 10-16.
• 27. Folland ED, Hartigan PM, Parisi AF. percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris :outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. J Am Coll Cardiol 1997;29:1505-11
• 28. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancetl997; 350: 461-68
• 29. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KAA, Julian DG, Chamberlain DA,_for the Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-Year Outcome in the RITA-2 Trial : Coronary Angioplasty Versus Medical Therapy. J Am Coll Cardiol 2003 ;42:1161-70
• 30. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterad GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti CR. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-43
• 31. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, Pileggi F. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26:1600-5.
• 32. Hueb W, Soares PR, Gersh BJ, Cesar LAM, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JAF. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004;43:1743-51.
• 33. Pitt B, Waters D, Brown WV, Van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS. Agressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999;341:70-6.
• 34. European Coronary Surgery Study Group. Long-term results of prospective randomized study of coronary artery by-pass surgery in satble angina pectoris. Lancet 1982;2:1173-1180
• 35. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration Coronary Artery Bypass Surgery Cooperative Study. N Engl J Med l984;311:1333-1339
• 36. Killip P, Passamani E, Davis K, and the CASS Principal Investigators and their associates. Coronary Artery Surgery Study (CASS) : a randomized trial of coronary bypass surgery. Circulation 1985;72(Suppl V):V-102-109
• 37. Yusuf S, Zucker D, Passamani E, Peduzzi P, Takaro T, Fisher LD, Kennedy JW, Davis K, Killip T, Norris R, Morris C, Mathur V, Varnauskas E, Chalmers TC. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-570
• 38. Goy JJ, Eeckhout E, Vogt P, Stauffer JC, Kappenberger L, Burnand B, Hurrii M, Stumpe F, Ruchat P, Sadeghi H. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994;343:1449-1453
• 39. Rodriguez A, Mele E, Peyregne E, Bullon F, Perez-Balino N, Liprandi MIS, Palacios IF. Three-Year Follow-Up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol 1996;27:1178-1184
• 40. King SB, III, Lembo NJ, Weintraub WS for the EAST Investigators. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044 -50
• 41. The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
• 42. The RITA Investigators. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573- 80.
• 43. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995;346:1179-84.
• 44. King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS, for the Emory Angioplasty Versus Surgery Trial (EAST) Investigators. Eight-Year Mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116 -21
• 45. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB, Hamm CW, Puel J, Hueb W, Goy JJ, Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-1189
• 46. The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-1129
• 47. Berger PB, Velianou JL, Vlachos HA, Feit F, Jacobs AK, Faxon DP, Attubato M, Keller N, Stadius ML, Weiner BH, Williams DO, Detre KH, on behalf of the BARI Investigators. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. J Am Coll Cardiol 2001;38:1440-1449
• 48. Weintraub WS, Stein B, Kosinski A, Douglas JS, Ghazzal ZMB, Jones EL, Morris DC, Guyton RA, Craver JM, King SB III. Outcome of Coronary Bypass Surgery Versus Coronary Angioplasty in Diabetic Patients With Multivessel Coronary Artery Disease. J Am Coll Cardiol 1998 ;31:10 -9
• 49. Locker C, Mohr R, Lev-Ran O, Uretzky G, Frimerman A, Shaham Y, Shapira I. Comparison of Bilateral Thoracic Artery Grafting With Percutaneous Coronary Interventions in Diabetic Patients. Ann Thome Surg 2004;78:471-6
• 50. Legrand VMG, Serruys PW, Unger F, van Hout BA, Vrolix MCM, Fransen GMP, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz e Melo JMG, dos Santos Neves JPM, Lindeboom W, Backx B, on behalf of the Arterial Revascularization Therapy Study (ARTS) Investigators. Three-Year Outcome After Coronary Stenting Versus By-pass Surgery for the Treatment of Multivessel Disease. Circulation.2004;109:1114-1120
• 51. The SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized controlled trial Lancet 2002; 360: 965-70
• 52. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J,Vogel D, Grinfeld R, Delacasa A, Garrido M, Oliveri R, Mele E, Palacios I, O'Neill W, for the ERACI II Investigators. Argentine Randomized Study : Coronary Angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERA-CI II) : 30-Day and One-year follow-up results. J Am Coll Cardiol 2001;37:51-58
• 53. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan K, Weiman D, Saucedo J, Antakli T, Para-mesh V, Pert S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D, for the In¬vestigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery for Patients With Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Out¬comes With Bypass: A Multicenter, Randomized Trial. J Am Coll Cardiol 2001;38:143-9
• 54. Goy JJ, Kaufmann U, Goy-Eggenberger D, Garachemani A, Hurni M, Carrel T, Gaspardone A, Burnand B, Meier B, Versaci F, Tomai F, Bertel O, Pieper M, de Benedictis M, Eeckhout E. A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc 2000;75:1116-23.
• 55. Morice MC, Serruys PW, Sousa E, Fajadet J, Hayashi EB, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R, for the Ravel Study Group. A randomized comparison of a sirolimus eluting stent with a standart stent for coronary revascularization. N Engl J Med 2002;346:1773-1780
• 56. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A metaanalysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003 ;41:1293-304.
• 57. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, Culliford AT, Isom OW, Gold JP, Rose EA. Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation. N Engl J Med 2005;352:2174-83.
• 58. Fuster V.Epidemic of cardiovascular disease and stroke: The three main challenges. Circulation 1999: 1132-1137
• 59. Murrey CJ, Lopez AD Mortality by cause for eight regions of the world:Global Burden of disease study, Lancet 1997c 349c 1269-1276
• 60. Braunwald's, Heart Disease, 7th Ed.2005, p,8
• 61. Napolic, Glas CK, Witztum JL, et al: Influence maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in children (FELİC) study. Lancet 1999; 354:1234-1241
• 62. Collins R, Petro R, Mac Mahon S et al. Blood Pressure, Stroke and Coronary Artery Disease. Part 2: Short-term reductions in blood pressure. Overviw of randomized drug trial in their epidemiological context. Lancet 1999;335827-838
• 63. Collaborative meta-analysis of randomized trials of atiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324: 71-86, 2002
• 64. Anglo-Scandinavian Cardiac Outcomes Trial(ASCOT), 2005,p,83
• 65. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20, 536 high-risk idividuals: a randomized placebocontrolled trial. Lancet 2002;360-362
• 66. La Rosa JC, He J, Vupputuri S:Effect of statins on risk of coronary disease: A meta-analysis of randomized conrolled trials. JAMA 282;2340-2346,1999
• 67. Tuomilehto J, Lindstrom J, Ericsson JG, et akReduction in the içidence of type 2 diabetes with lifestyle among subjects with impaired glucose tolerance New Engl J Med 344:1343-1350,2001
• 68. Knowler WC-, Barrett-Connor E, Fowler SE, et al: Reduction in the icidence of type;2 diabetes with lifestyle intervention or metformi. N Engl JMedi346:393,403,2002
• 69. Howward G, Wagenknecht LE, Burke GL, et al: Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Cmmunities (ARIC) study, JAMA 279:119,1998
• 70. Critchley JACapewell S: Mortality, risk reduction associatet with smoking cessation in patients with coronary heart disease: A systematic review. JAMA 290:86,2003
• 71. De Longeril MSulen P, Martin JR, et akMediterranean diet, traditional risk factors and the rate of cardiovascular cmplications after myocardial infarction. Circulation 1999,99:779
• 72. Ornish D, Brown SE, Scherwitz LW, et al: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart. Lancet 1990;336:129
• 73. Robert J.De Winter, MD,.,Ph.D., Fons Windhause MD et al: Early Invasive vesuis Selectively Invasive Management for Acutee Coronary Syndromes, New Engl J Med 353: 1095-1104
• 74. Pitt B, Waters D, Brown W: Agressve lipid lowering compared with angioplasty in stable coronary artery disease. N Eng J Med 341: 70,1999
• 75. Prosser LA; Stinnett AA, Goldman PA, et al: Cost effectiveness of cholesterol lowering therapies according to selected patient characteristics. Ann Intern Med 132:769-774,2000
• 76. Ryan TJ, Antman EM, Brooks NH, et al: 1999 update: ACC/AHA guidelines for management of patients with acute myocardial infarction: A repot of American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am coll Cardiol, 1999:34:904
• 77. Hampton JR, Schroder R, Wilcox, et al: Randomized, double-blind comparison of reteplase double - bolus administration with strepto-kinase in acute myokardial infarction (INJECT): trial to investigate equivalence.Lancet 1995;346:329
• 78. G, Parodi, G Memisha, R Walanti et al: Five year outcome after primary coronary intervention for acute ST elevation myocartdial infarction: results from single centre experience Herat 2005; 91:1541- 1544
• 79. Yusuf S, Zücker D, Peduzzi P, Fisher LD, Takarot, T, et al: Effect of coronary artery bypass graft on survavial. Lancet 1994; 344,1446
• 80. Schwartz L, Kip KE Frye RL, et al: Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty. Revascularization investigation (BARI). Circulation; 106: 2652-2658,2002
• 81. Lincoff Am: Important triad cardiovascular medicine: Diabetes, coronary intervention and platelet glycoprotein Ilb'III a receptor blokade. Circulation; 107: 1556,2003
• 82. Knatterud GL, Rosenberg Y, Campeau L, et al: Long term effects on clinical outcomes of agressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation; 102: 157-165,2000
• 83. Novegian Multicenter Study Group: Timolol-İnduced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304:801
• 84. Becker RC: Antiplatelet therapy in coronary heart disease: Emerging strategies fort he treatment and preventin of myocardial infarctin. Arc Pthol Lab Med 1993; 117:89
• 85. HOPE Inestigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluatin study investigators.N Engl J Med 2000;342: 145
• 86. Nehler MR, Krupski WC. Cardiac complications and surgery. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: WB Saunders Company, 2000; 626-646).
• 87. Hancock EW. Aortic stenosis, angina pectoris, and coronary artery disease. Am Heart J 1977; 93: 382-393.
• 88. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short- term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40:418-23.
• 89. D Kron İL, Bayfield MS. Coronary artery bypass. Reoperation. In: Kaiser LR, Kron IL, Thomas LS, editors. Mastery of Cardiothoracic Surgery. New York: Lippincot- Raven; 1998. pp. 420-30.
• 90. Shapira I, Isakov A, Heller I, Topilsky M, Pines A. Longterm follow- up after coronary artery bypass grafting reoperation. Chest 1999; 115: 1593-7.
• 91. Kolessov VI Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967; 54:535-44.
• 92. Benetti FJ, Nusseli G, Wood M Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 1991100:312-6.
• 93. Calafiore AM,Di Giammarco, G Tedori G Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 1996; 61:1658-65.
• 94. Subramanian VA Less invasive arterial CABG on a beating heart. Ann Thorac Surg 1997; 63:68-71.
• 95. Shennib H, Allan GL, Akin J. Safe and effective method of stabilization of coronary artery bypass grafting on the beating heart. Ann Thorac Surg 1997; 63:998-2.
• 96. Kirsch M, Guesnier L, LeBesnerais, et al. Cardiac operations in octogenarians: Perioperative risk factors for death and impaired autonomy. Ann Thorac Surg 1998; 66: 60-67
• 97. Fruitman DS, MacDougall CE, Ross DB. Cardiac surgery in octogenarians: Can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg 1999; 68: 2129-2135.
• 98. Peterson ED, Cowper PA, Jollis JG, et al. Outcomes of coronary Nartery bypass graft surgery in 24461 patients aged 80 years or older. Circulation 1995; 92(Suppl 9): 11-85-91.
• 99. Ö. Yorgancıoğlu C, Tezcaner T, Tokmakoğlu H, et al. İleri yaş grubunda koroner bypass deneyimi. GKDC Dergisi 1999; 7: 30-35.
• lOO. McGrath LB, Adkins MS, Chen C, et al. Actuarial survival and other events following valve surgery in octogenarians: comparison with an age-sex and race-matched population. Eur J Cardiothorac Surg 1991; 5:319-325.
• lOl. Bennetti FJ. Direct coronary surgery with sphenoid vein bypass without either cardiopulmonary bypass or cardiac arrest. J Cardiovasc Surg 1985; 26: 217-22.
• 102. Buffolo E, Andrade JC, Succi J, Leao LE, Galluci C. Direct myocardial revascularization without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987;33: 26-9.
• 103. Chen X, Xu M, Shi H, Mu X, Chen Z, Qiu Z: Comparative study of on-pump and off-pump coronary bypass surgery in patients with triple-vessel coronary artery disease. Chin Med J 2004; 117: 342-346. 104. Hu S, Wang X, Song Y, Lu F. Graft patency in off-pump and conventional coronary artery bypass grafting for treatment of triple vessel coronary disease. Chin Med J 2003; 116: 436-439.
• 105. Calafiore AM, Maure M, Canosa C, Giammarco G, Iaco AL, Contini M. Early and late outcome of myocardial revascularization with and without cardiopulmonary bypass in high risk patients (EuroSCO-RE>6). Eur J Cardiothorac Surg 2003; 23: 360-367.
• 106. Cooley DA Con: beating heart surgery for coronary revascularisation: Is it the most important development since the introduction of the heart lung machine? Ann Thorac Surg, 2000; 70: 1779 .
• 107. Mohr FW, Falk V, Diegeler A, et al. Computer enhanced "robotic" cardiac surgery: experience in 148 patients.JThoracCardiovasc-Surg2001; 121:842-53. 108.Kappert U, Schneider J, Matschke K, et al. Development of robotic enhanced endoscopic surgery for the treatment of coronary artery disease. Circulation 2001;104(Suppll):1102-7.
• 109. Dogan S, Aybek T, Andressen E, et al. Totally endoscopic coronary bypass grafting on cardiopulmonary bypass with robotically enhanced telemanipulation: report on forty-five cases. J Thorac Cardiovasc Surg 2002; 123:1125-31 .
• 110. Fruitman DS, MacDougall CE, Ross DB. Cardiac surgery in octogenarians: Can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg 1999; 68: 2129-2135.
• 111. Emiroğulları ÖN, Ceyran H, Tezcaner T, et al. 65 yaş ve üzerindeki hastalarda koroner arter cerrahisi. T Klin Kapl-Damar Cerrahisi 2000, 1:51-54.
• 112. Craver JM, Puskas JD, Weintraub WW, et al. 601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann Thorac Surg 1999; 67: 1104-1110.
• 113. Eagle and Guyton et al. ACC/AHA Guidelines for CABG Surge. JACC1999;34: 1262-1347.
• 114. DM Cosgrove, FD Loop, CL Saunder, BM Lytle, JR Kramer. Should coronary arteries with less than fifty percent stenosis be bypassed? Thoracic, and Cardiovascular Surgery, 1981; 82: 520-530.
• 115. Lytle BW, Loop FD, Cosgrove DM, et al. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Throac Cardiovasc Surg 1985; 89: 248-58.
• 116. Loop FD, Lytle BW, Cosgrove DM, et al. _____nfluence of the internal-mammary-artery graft on 10-year survival and other cardiac eents. N EnglJMedl986;314: 1-6.
• 117. Lytle BW, Loop FD, Taylor PC, et al. Vein graft disease: The clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Throac Cardiovasc Surg 1992; 103: 831-40.
• 118. Platko WP, Hollman J, Whitlow PL, Franco I. Percutaneous vs transluminal angioplasty of saphenous vein graft stenosis: Long-term follow-up. JACC 1989; 14: 1645-50.
• 119. Buckberg GD, Beyersdorf F, Kato NS. Technical considerations and logic of antegrade and retrograde cardioplegic delivery. Semin Thorac Cardiovasc Surg 1993; 5: 125-33.